FDA product code JBL: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative

JBL is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), quantitative. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel. FDA has cleared 2 510(k) submissions under JBL, from 2 different applicants. The average 510(k) review took 46 days (median 46). FDA has posted 2 recalls for JBL devices.

Classification

FieldValue
Device nameGlucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative
Device classClass II
Regulation21 CFR 864.7360
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every JBL clearance

Top JBL applicants

ApplicantClearancesLatest
Astoria-Pacific, Inc.11999-05-11
Sigma Chemical Co.11979-03-15

Most recent JBL clearances

510(k)ApplicantDeviceDecision dateReview days
K990957Astoria-Pacific, Inc.ASTORIA-PACIFIC SPOTCHECK G6PD KIT 50 HR, MODEL 80-3000-13K1999-05-1150
K790211Sigma Chemical Co.DEHYDROGENOSE, GLUCOSE PHOSPHATE1979-03-1543

Recalls for JBL devices

2 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2019-04-03.

YearRecalls
20192

Frequently asked questions

What is FDA product code JBL?

JBL is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), quantitative. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel.

What device class is JBL?

Class II, regulation 21 CFR 864.7360. Typical premarket route: 510(k).

How long does a 510(k) take for product code JBL?

Across 2 cleared submissions the average was 46 days from receipt to decision (median 46).

Which companies have the most JBL clearances?

Astoria-Pacific, Inc. (1); Sigma Chemical Co. (1).

Have JBL devices been recalled?

Yes: 2 product recalls across 1 recall events; the most recent began 2019-04-03.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times